Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017*
Expected consequences of moving US pharma manufacturing to the US
This statistic shows the results of a survey conducted in the United States in February 2017. U.S. adults were given a list of 11 options and asked to select which consequences they would expect if U.S. pharma companies were forced to move their manufacturing from abroad back to the U.S. About 42 percent of respondents said that they believe higher drug prices would be an expected consequence, while 10 percent of respondents thought that a decrease in manufacturing companies would be a consequence.
Opinions on consequences in case U.S. pharma companies would be forced to manufacture in-country as of 2017*
Percentage of respondents
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2017

Region

United States

Survey time period

February 6 to 8, 2017

Number of respondents

1,029 respondents

Age group

18 years and older

Method of interview

Online survey

Supplementary notes

* Original question: "A lot of US pharma companies manufacture abroad. Which consequences do you expect in case pharma companies were forced to manufacture in the US?"

Expected consequences of moving US pharma manufacturing to the US
This statistic shows the results of a survey conducted in the United States in February 2017. U.S. adults were given a list of 11 options and asked to select which consequences they would expect if U.S. pharma companies were forced to move their manufacturing from abroad back to the U.S. About 42 percent of respondents said that they believe higher drug prices would be an expected consequence, while 10 percent of respondents thought that a decrease in manufacturing companies would be a consequence.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.